Skip to main navigation Skip to search Skip to main content

Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease

  • W H Wilson Tang
  • , Zeneng Wang
  • , David J Kennedy
  • , Yuping Wu
  • , Jennifer A Buffa
  • , Brendan Agatisa-Boyle
  • , Xinmin S Li
  • , Bruce S Levison
  • , Stanley L Hazen

Research output: Contribution to journalArticle

Abstract

Trimethylamine-N-oxide (TMAO), a gut microbial-dependent metabolite of dietary choline, phosphatidylcholine (lecithin), and l-carnitine, is elevated in chronic kidney diseases (CKD) and associated with coronary artery disease pathogenesis.
Original languageEnglish
Number of pages392
JournalCirculation research
Volume116
Issue number3
StatePublished - 2015

Cite this